Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpirax-Sarco Regulatory News (SPX)

Share Price Information for Spirax-Sarco (SPX)

Share Price is delayed by 15 minutes
Get Live Data
6,555.00    160.00 (2.50%)
Bid:
6,545.00
Ask:
6,550.00
Spread: 5.00 (0.076%)
Market Cap: £4.84b
SPX Live PriceLast checked at - London Stock Exchange

Intraday Spirax-Sarco Share Chart

Directorate Change

10 Feb 2009 12:37

RNS Number : 0867N
Spirax-Sarco Engineering PLC
10 February 2009
 



10th February 2009

STOCK EXCHANGE ANNOUNCEMENT

BOARD CHANGES AT SPIRAX-SARCO ENGINEERING PLC

The Board of Directors of Spirax-Sarco Engineering plc announces the following changes in the Board to take account of retirements and changing roles. These changes are designed to continue to strengthen the Board and support the development of the Group's successful businesses. Spirax Sarco is the world leader in providing engineered solutions for the steam-using and peristaltic pump markets.

Dr Krishnamurthy Rajagopal (age 55) is appointed as an independent non-executive director with effect from 10th Febrary 2009, replacing Einar Lindh whose retirement on 31st December 2008 was announced previously. Dr Rajagopal was previously a main board director of BOC Group plc and Chief Executive of BOC Edwards.

Dr Rajagopal is currently a non-executive director of Dyson Group plc, WS Atkins plc and Bodycote plc. He is also an Audit Commissioner. Until April 2008 he was a non-executive director of Foseco plc. He is a member of the Council for Science and Technology, the Prime Ministerial advisory body, and a Member of the Advisory Board of the Centre for Business Research at Cambridge University. Dr Rajagopal will join the Audit, Remuneration and Nomination Committees and we look forward to his making a strong contribution to the Board.

Alan Black will be leaving the Board on 30th April 2009 realising his long-held intention to retire early. Alan started work at Spirax in 1981 and came onto the Board in 1998. During his long career at Spirax, Alan has been responsible for many of the Group's operating companies in Asia and Europe, and is currently responsible for the company's steam business in Asia, the UK/ROI and South America. Alan has helped to develop those businesses and we thank him for much of the growth and development in those markets in recent years.

We welcome Michael Gibbin (age 46) to the Board from 1st May 2009 as an executive director with responsibility for the company's manufacturing operations in Cheltenham and Châtellerault, France, the company's steam business operations in North America, Cheltenham-based product development and Group-wide health & safety. Mike joined Spirax in 2007 responsible for the Group's manufacturing operations in Cheltenham. He brings previous relevant experience in new product development, manufacturing and general management from the automotive industry, working previously as Chief Executive of Comau Sweden (Fiat) and senior engineering manager for Honda. Mike graduated in mechanical engineering and is a chartered engineer. We look forward to him making a strong contribution to the future development of the Group.

In connection with Mike's appointment, Tony Scrivin will assume responsibility for the company's steam business operations in the UK, Europe and Africa, and Neil Daws will assume responsibility for the company's steam business in the Asia Pacific region and South America.

There are no further disclosures to be made pursuant to Listing Rule 9.6.13.

Enquiries:

Mark E Vernon

Chief Executive

Mike Townsend

Chairman

Spirax-Sarco Engineering plc

Charlton House

Cheltenham, Glos.

GL53 8ER

Tel: 01242 521361

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOABDGDDSXBGGCG
Date   Source Headline
7th Feb 20205:35 pmRNSDirector Declaration
13th Nov 20197:00 amRNSTrading Update
10th Sep 20193:30 pmRNSChange of Director Details
4th Sep 201910:00 amRNSBoard Change
21st Aug 20192:49 pmRNSHolding(s) in Company
14th Aug 20199:02 amRNSHolding(s) in Company
9th Aug 201910:27 amRNSDirector/PDMR Shareholding
8th Aug 20194:26 pmRNSDirector/PDMR Shareholding
7th Aug 20197:00 amRNSHalf-year Report
1st Aug 20195:41 pmRNSChange of Adviser
28th May 20193:08 pmRNSHolding(s) in Company
17th May 20194:16 pmRNSDirector/PDMR Shareholding
16th May 20194:12 pmRNSHolding(s) in Company
15th May 20195:14 pmRNSResult of AGM
15th May 20197:05 amRNSBoard Changes
15th May 20197:00 amRNSAGM Statement - Trading Update
13th May 20192:45 pmRNSCompletion of Acquisition
30th Apr 20199:21 amRNSChange of Director Details
25th Apr 20198:28 amRNSChange of Director Details
11th Apr 20192:36 pmRNSDirector/PDMR Shareholding
15th Mar 201911:25 amRNSAcquisition
7th Mar 20197:00 amRNSFinal Results
1st Mar 20193:04 pmRNSBoard Appointment
18th Feb 20197:00 amRNSExclusive negotiations to acquire Thermocoax
16th Jan 20194:20 pmRNSChange of Director Details
3rd Dec 20187:00 amRNSDisposal
15th Nov 20187:00 amRNSTrading Update
31st Oct 20184:23 pmRNSDirector/PDMR Shareholding
12th Oct 20185:34 pmRNSDirector/PDMR Shareholding
26th Sep 20187:30 amRNSChange of Director Details
20th Sep 201811:16 amRNSHolding(s) in Company
23rd Aug 20184:55 pmRNSHolding(s) in Company
9th Aug 20183:07 pmRNSDirector/PDMR Shareholding
8th Aug 20187:00 amRNSHalf Year Results
31st Jul 201810:22 amRNSHolding(s) in Company
25th Jul 20189:46 amRNSChange of Director Details
20th Jul 201810:00 amRNSExecutive Director Promotion
11th Jun 20184:26 pmRNSHolding(s) in Company
31st May 20188:12 amRNSDirector/PDMR Shareholding
17th May 20189:26 amRNSDirector/PDMR Shareholding
15th May 20184:55 pmRNSResult of AGM
15th May 20187:00 amRNSAGM Statement - Trading Update
25th Apr 20184:27 pmRNSDirector/PDMR Shareholding
6th Apr 20183:32 pmRNSDirector/PDMR Shareholding
4th Apr 20184:17 pmRNSDirector/PDMR Shareholding
29th Mar 20184:24 pmRNSTotal Voting Rights
29th Mar 20184:20 pmRNSDirector/PDMR Shareholding
15th Mar 20187:00 amRNS2017 Preliminary Results
6th Mar 20187:00 amRNSBoard Appointment
14th Feb 20187:00 amRNSBoard Succession Changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.